Loading the map…
Other social work activities without accommodation n.e.c. · Wrexham
Novel Health Solutions
Novel Health Solutions Ltd
Private limited company registered in Wrexham, classed under “Other social work activities without accommodation n.e.c.”.
Headline figures
FY to Jun 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2023 | 2024 | 2025 |
|---|---|---|---|
| Profit after tax | — | ||
| Turnover | |||
| Net assets | |||
| Cash | |||
| Employees |
Every figure for all 3 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current assets | |||
| of which cash | |||
| Net current assets | |||
| Net assets |
4 balance-sheet lines, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Novel Health Solutions do?
Private limited company registered in Wrexham, classed under “Other social work activities without accommodation n.e.c.”.
›How much turnover does Novel Health Solutions make?
Answered in the full report
›Is Novel Health Solutions profitable?
Novel Health Solutions's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Novel Health Solutions?
Answered in the full report
›Where is Novel Health Solutions based?
Its registered office is 2 Ffordd Glyn, Coed-Y-Glyn, Wrexham, LL13 7QN, in Wrexham.
›When was Novel Health Solutions founded?
Novel Health Solutions Ltd was incorporated on 17 June 2022.
›Is Novel Health Solutions still trading?
The register lists Novel Health Solutions Ltd as active.